Clinical Trial Update: Efficacy of Dolutegravir Plus Lamivudine in HIV-1-infected Treatment-naïve Adults Without a Baseline Genotyping Test [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating efficacy of dolutegravir plus lamivudine in treatment-naïve HIV-1–infected adults without baseline genotyping.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Disease
• HIV Infection

Drugs mentioned

• Dolutegravir (dolutegravir)
• Lamivudine (lamivudine)

Snippet

Sponsor: Fundacion IDEAA | Conditions: Hiv, HIV-1-infection | Phase 4 | Status: COMPLETED